Tags: Drug.

Vestipitant is a drug developed by GlaxoSmithKline which acts as a selective antagonist for the NK1 receptor. It is under development as a potential antiemetic and anxiolytic drug and as a treatment for tinnitus and insomnia.

Vestipitant_structure.png
ATC prefix
none
CAS number
334476-64-1
FDA UNII code
S052TOI9BI
IUPAC name
(2S)-N-[(1R)-1-[35-bis(trifluoromethyl)phenyl]ethyl]-2-(4-fluoro-2-methylphenyl)-N-methylpiperazine-1-carboxamide
PubChem
9832383

Loading...

This page contains content from the copyrighted Wikipedia article "Vestipitant"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.